Literature DB >> 27548276

Effect of Localizer Radiography Projection on Organ Dose at Chest CT with Automatic Tube Current Modulation.

Natalia Saltybaeva1, Andreas Krauss1, Hatem Alkadhi1.   

Abstract

Purpose To calculate the effect of localizer radiography projections to the total radiation dose, including both the dose from localizer radiography and that from subsequent chest computed tomography (CT) with tube current modulation (TCM). Materials and Methods An anthropomorphic phantom was scanned with 192-section CT without and with differently sized breast attachments. Chest CT with TCM was performed after one localizer radiographic examination with anteroposterior (AP) or posteroanterior (PA) projections. Dose distributions were obtained by means of Monte Carlo simulations based on acquired CT data. For Monte Carlo simulations of localizer radiography, the tube position was fixed at 0° and 180°; for chest CT, a spiral trajectory with TCM was used. The effect of tube start angles on dose distribution was investigated with Monte Carlo simulations by using TCM curves with fixed start angles (0°, 90°, and 180°). Total doses for lungs, heart, and breast were calculated as the sum of the dose from localizer radiography and CT. Image noise was defined as the standard deviation of attenuation measured in 14 circular regions of interest. The Wilcoxon signed rank test, paired t test, and Friedman analysis of variance were conducted to evaluate differences in noise, TCM curves, and organ doses, respectively. Results Organ doses from localizer radiography were lower when using a PA instead of an AP projection (P = .005). The use of a PA projection resulted in higher TCM values for chest CT (P < .001) owing to the higher attenuation (P < .001) and thus resulted in higher total organ doses for all investigated phantoms and protocols (P < .001). Noise in CT images was lower with PA localizer radiography than with AP localizer radiography (P = .03). The use of an AP projection allowed for total dose reductions of 16%, 15%, and 12% for lungs, breast, and heart, respectively. Differences in organ doses were not related to tube start angles (P = .17). Conclusion The total organ doses are higher when using PA projection localizer radiography owing to higher TCM values, whereas the organ doses from PA localizer radiography alone are lower. Thus, PA localizer radiography should be used in combination with reduced reference tube current at subsequent chest CT. © RSNA, 2016 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2016        PMID: 27548276     DOI: 10.1148/radiol.2016160384

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Organ doses from CT localizer radiographs: Development, validation, and application of a Monte Carlo estimation technique.

Authors:  Jocelyn Hoye; Shobhit Sharma; Yakun Zhang; Wanyi Fu; Francesco Ria; Anuj Kapadia; W Paul Segars; Joshua Wilson; Ehsan Samei
Journal:  Med Phys       Date:  2019-09-16       Impact factor: 4.071

2.  Explore the Value of Dual Source Computer Tomography Automatic Tube Current Regulation in Reducing the Radiation Dose of CTA in Lower Extremity Vessels.

Authors:  Xin Hu; Yi Yu
Journal:  Front Surg       Date:  2022-05-03

3.  Establishing how patient size and degree of miscentring affect CTDIvol, using patient data from a dose tracking system.

Authors:  Sean Cournane; Eimear Brunell; Michael Rowan
Journal:  Br J Radiol       Date:  2019-06-05       Impact factor: 3.039

4.  0° vs. 180° CT localiser: The effect of vertical off-centring, phantom positioning and tube voltage on dose optimisation in multidetector computed tomography.

Authors:  Yazan Al-Hayek; Xiaoming Zheng; Rob Davidson; Christopher Hayre; Dana Al-Mousa; Campbell Finlay; Kelly Spuur
Journal:  J Med Radiat Sci       Date:  2021-08-17

Review 5.  Benefits of Low-Dose CT Scan of Head for Patients With Intracranial Hemorrhage.

Authors:  Dan Wu; Gang Wang; Bingyang Bian; Zhuohang Liu; Dan Li
Journal:  Dose Response       Date:  2020-03-06       Impact factor: 2.658

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.